Closed
SectorHealthcare
2.21 6.25
24h
Min
2.02
Max
2.23
Income | 17M -34M |
---|---|
Sales | -1.5M 5.1M |
EPS | -0.12 |
Profit margin | -677.426 |
Employees | 596 |
EBITDA | -3.4M -55M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +455.02% upside |
Next Earnings | 6 maj 2025 |
---|
Market Cap | -13M 690M |
---|---|
Previous open | -4.04 |
Previous close | 2.21 |
By Acuity
34%
66%
116 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 11.6 USD 455.02%
High 28 USD
Low 4 USD
Based on 7 Wall Street analysts offering 12 month price targets forAbCellera Biologics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$